Clinical Trials Directory

Trials / Completed

CompletedNCT03818490

Aromatherapy for Anxiety Among Children With Autism Spectrum Disorder

Bergamot Aromatherapy for Anxiety in a Medical Office Among Children With Autism Spectrum Disorder: A Randomized, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Nutraceuticals Research Institute · Academic / Other
Sex
All
Age
6 Years – 11 Years
Healthy volunteers
Accepted

Summary

This study evaluated the use of bergamot aromatherapy in the treatment of anxiety in a medical office setting among children who are diagnosed with an autism spectrum disorder. H

Detailed description

Bergamot aromatherapy relieves anxiety in adult populations but has not been tested in a pediatric population with autism spectrum disorder. Because autism spectrum disorders often include hypersensitivity to sensory experiences, the use of essential oils in this population should be evaluated.

Conditions

Interventions

TypeNameDescription
OTHERBergamot AromatherapyPatients in this group inhaled bergamot essential oil for 15 minutes.

Timeline

Start date
2016-06-24
Primary completion
2018-03-09
Completion
2018-03-30
First posted
2019-01-28
Last updated
2019-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03818490. Inclusion in this directory is not an endorsement.